Q3 2024 Cibus Inc Earnings Call Transcript
Key Points
- Cibus Inc (CBUS) has successfully transitioned from an R&D-based business to the first commercial gene editing company in the industry.
- The company has developed a 'trait machine' process that significantly reduces the time required for trait development, achieving results in less than 12 months.
- Cibus Inc (CBUS) has established collaborations with major seed companies, enhancing its commercial potential and validating its technology.
- The company has made significant progress in developing herbicide-resistant traits in rice and pod shatter reduction traits in canola, with successful field trials.
- Cibus Inc (CBUS) is well-positioned to capture market opportunities in rice and canola, with potential annual royalties estimated at $200 million and $150 million, respectively.
- Cibus Inc (CBUS) reported a net loss of $201.5 million for the third quarter of 2024, primarily due to the impairment of goodwill.
- The company's cash and cash equivalents are expected to fund operations only through the first quarter of 2025, indicating potential liquidity concerns.
- There is uncertainty regarding the regulatory environment for gene editing in Europe and Asia, which could impact future market opportunities.
- The commercialization of traits in the U.S. and Europe is expected to take longer due to regulatory processes, delaying potential revenue streams.
- Cibus Inc (CBUS) is still in the early stages of proving its business model, with initial edits being done at the company's expense before transitioning to a cost-sharing model with partners.
Good day, and welcome to the Cibus third quarter, 2024 Earnings Conference Call. All participants will be in listen-only mode.
(operator instructions) Please note, today's event is being recorded. I would now like to turn the conference over to Carlo Broos, Chief Financial Officer. Please go ahead. Thank.
Thank you, and good afternoon. I would like to thank you for taking time to join us for Cibus third quarter 2024 financial results and business update conference call and webcast.
Presenting with me today is Rory Riggs, our Co-Founder, Chief Executive Officer and Peter Beetham, Co-Founder, President and Chief Operating Officer.
Before we begin the call, I would like to remind everyone that statements made on the call and webcast, including those regarding future financial results and future operational goals and industry prospects are forward-looking and may be subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
